Yesterday, while the Supreme Court of Appeal heard the arguments between Aventis, Cipla and TAC regarding whether to grant an interim interdict to prevent Cipla from producing generic docetaxel, an interesting debate on South Africa’s use of the TRIPS flexibilities was published on Druginfo Digest. The debate was ignited by the case and Anso’s article […]
READ MORESouth Africa is currently developing a policy for intellectual property protection in the country. On 19 August 2011 it was reported that Jodi Scholtz, group COO of the DTI stated: “The Department of Trade and Industry (DTI) intends to submit the Intellectual Property (IP) draft policy to Cabinet next month to secure approval to undertake […]
READ MOREA Treatment Action Campaign briefing document Background The Agreement on Trade Related Aspects of Intellectual Property (“the TRIPS agreement”), effective from 1 January 1995, set standards of intellectual property protection that member states of the World Trade Organisation (WTO) are required to uphold in their own national laws.[1] The TRIPS agreement requires WTO member countries […]
READ MOREPatents Act No 57 of 1978 as last amended in 2002 Patents Amendment Act No 20 of 2005
READ MORE